Bioventus Inc (BVS)
11.51
+0.10
(+0.88%)
USD |
NASDAQ |
Nov 21, 16:00
11.52
+0.01
(+0.09%)
After-Hours: 20:00
Bioventus Revenue (Quarterly): 138.96M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 138.96M |
June 30, 2024 | 151.22M |
March 31, 2024 | 129.46M |
December 31, 2023 | 135.42M |
September 30, 2023 | 120.79M |
June 30, 2023 | 137.07M |
March 31, 2023 | 119.06M |
December 31, 2022 | 125.83M |
September 30, 2022 | 128.66M |
June 30, 2022 | 140.33M |
March 31, 2022 | 117.29M |
Date | Value |
---|---|
December 31, 2021 | 130.41M |
September 30, 2021 | 108.89M |
June 30, 2021 | 109.82M |
March 31, 2021 | 81.78M |
December 31, 2020 | 98.59M |
September 30, 2020 | 85.91M |
June 30, 2020 | 58.02M |
March 31, 2020 | 78.64M |
December 31, 2019 | 97.55M |
March 31, 2016 | 65.40M |
March 31, 2015 | 53.36M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
58.02M
Minimum
Jun 2020
151.22M
Maximum
Jun 2024
114.69M
Average
119.93M
Median
Revenue (Quarterly) Benchmarks
Boston Scientific Corp | 4.209B |
Insulet Corp | 543.90M |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | 27.94M |
Catheter Precision Inc | 0.096M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -4.824M |
Total Expenses (Quarterly) | 132.38M |
EPS Diluted (Quarterly) | -0.07 |
Enterprise Value | 1.131B |
Gross Profit Margin (Quarterly) | 67.32% |
Profit Margin (Quarterly) | -3.47% |
Earnings Yield | -5.21% |
Operating Earnings Yield | 2.39% |
Normalized Earnings Yield | -1.186 |